The Impact of Post-tetanic Count on Subsequent Train-of-four During Recovery From Rocuronium
NCT01086176 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 22
Last updated 2010-04-27
Summary
The purpose of this study is to see how long does the effect of a post-tetanic facilitation last on subsequent train-of-four. The investigators hypothesis is that the effect last at least 30 minutes.
Conditions
- Post-tetanic Count on One Arm, the Other Arm is the Control
Interventions
- DEVICE
-
NMT (a device that can do neurostimulation and can record the response on the stimulation by Datex)
on one side, we do a post-tetanic count, on the other side we don't, after, we do train-of-four on both sides and check the difference
Sponsors & Collaborators
-
Maisonneuve-Rosemont Hospital
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-03-31
- Primary Completion
- 2010-04-30
- Completion
- 2010-04-30
Countries
- Canada
Study Locations
More Related Trials
-
Detecting Traumatic Intracranial Hemorrhage With Microwave Technology
NCT02728908 ·Status: COMPLETED ·Phase: NA
-
A Study to Compare How Well Gadoquatrane Works and Its Safety With an Already Available Contrast Agent for MRI in People With Known or Suspected Brain or Spinal Cord-related Problems
NCT05915702 ·Status: COMPLETED ·Phase: PHASE3
-
A Non-therapeutic Feasibility Study of the Radioligand [11C]-UCB-J for Imaging Synaptic Density
NCT03577262 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Safety and Efficacy of Gadobutrol 1.0 Molar in Japanese Subjects for CNS Imaging
NCT01660841 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Investigate the Regional Brain Kinetics of the Positron Emission Tomography Ligand [18F]-JNJ-70099731 in Healthy Male Participants
NCT04911543 ·Status: COMPLETED ·Phase: PHASE1
-
Repeatability in Hyperpolarized 3-Helium With MRI
NCT03776747 ·Status: COMPLETED ·Phase: PHASE4
-
An Imaging Study to Investigate the Distribution of GW842166X in the Brain.
NCT00511524 ·Status: COMPLETED ·Phase: PHASE1
-
Positron Emission Tomography of Amyloid in Alzheimer's Disease
NCT00205621 ·Status: SUSPENDED ·Phase: PHASE1
-
Evaluation of [11C]RO6924963, [11C]RO6931643, and [18F]RO6958948 as Tracers for Positron Emission Tomography (PET) Imaging of Tau in Healthy and Alzheimer's Disease (AD) Participants
NCT02187627 ·Status: COMPLETED ·Phase: PHASE1
-
Quantitative Evaluation of [18F]T807 as a Potential PET Radioligand for Imaging Tau in Patients With Alzheimer's Disease
NCT02370524 ·Status: COMPLETED ·Phase: PHASE1
-
Impact of Microglial Activation on Synaptic Density in Alzheimer's Disease
NCT05911178 ·Status: RECRUITING ·Phase: NA
-
Open Label, Adaptive, Parallel Group PET Study Using RO7017773 And [11C] RO15-4513
NCT03507569 ·Status: COMPLETED ·Phase: PHASE1
-
Growth Hormone or Sildenafil as Therapies for Fatigue in Mild- Traumatic-brain-injury (MTBI)
NCT02114775 ·Status: COMPLETED ·Phase: PHASE1
-
Exploring the Utility of [18F]3F4AP for Demyelination Imaging
NCT06999434 ·Status: RECRUITING ·Phase: PHASE1
-
Study to Find the Appropriate Dose of a New Gadolinium-based Contrast Agent (GBCA) for Adults Undergoing Magnetic Resonance Imaging (MRI) for Known or Highly Suspected Brain and/or Spinal Cord Conditions
NCT04307186 ·Status: COMPLETED ·Phase: PHASE2
-
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
NCT04373564 ·Status: RECRUITING ·Phase: PHASE4
-
Positron Emission Tomography Imaging of Dopamine Receptors Using the Tracer [11C]NNC-112
NCT00088517 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Evaluation of a Novel Balance, Vestibular and Oculomotor Assessment Tool
NCT02171312 ·Status: COMPLETED
-
Outcomes of Autologous Bone Marrow-derived Mononuclear Cell Transplantation in the Management of Neurological Sequelae
NCT05293873 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Evaluation of a Carbon Nanotube Enabled Solid-State Head CT
NCT04495634 ·Status: COMPLETED ·Phase: NA
-
ExAblate Blood-Brain Barrier Opening for Treatment of Alzheimer's Disease
NCT03739905 ·Status: COMPLETED ·Phase: NA
-
Hydroxyephedrine PET/CT in Sympathetic Nervous System Disease
NCT06951984 ·Status: RECRUITING
-
Evaluation of [18F]APN-1607 PET Uptake in Alzheimer's Disease Patients Compared With Healthy Subjects
NCT04141150 ·Status: UNKNOWN ·Phase: PHASE2
-
Assessment of 11C-JMJ-129 for Imaging PDE4D in Brain and Whole Body of Healthy Volunteers
NCT06874205 ·Status: RECRUITING ·Phase: PHASE1
-
In Vitro Study of the Effect of Gadolinium Contrast on Fibrocytes
NCT02512796 ·Status: UNKNOWN